- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
In an extremely successful year, Nanogate AG (ISIN DE 000A0JKHC9) achieved important goals, exceeded all targets and continued its growth course. Therefore the company improved its long-term sales and earnings perspectives significantly. Stronger financial reserves are reflected in a considerable rise in the equity ratio.
With publication of its consolidated financial statements, Nanogate confirmed the interim results. Group-wide sales in the financial year rose by 64% to €7.834 million (previous year: €4.763 million) due to increased demand for Nanogate products, new customers and several clients taking developments into mass production.
Adjusted for extraordinary events such as the stock market flotation, the consolidated result before earnings and taxes (EBIT) increased by approx. 200% to €1.02 million (previous year: €0.333 million). The EBIT margin almost doubled from 7 to 13%. The extraordinary result of €-1.382 million results mainly from IPO costs. As rules for accounting under the Commercial Code do not permit flotation costs to be deducted from IPO proceeds, there is a consolidated net loss of €-0.295 million (previous year: €0.245 million). The result per share amounts to €0.71 (adjusted for the extraordinary result). The company's financial situation improved considerably due to the healthy earnings situation and the proceeds from the stock market listing in the Entry Standard. At balance sheet date, liquid assets amounted to €12.858 million and the operative cash flow to €1.175 million. The average Days Sales Outstanding (DSO) improved from 33 to 19 days. The balance sheet total rose to €19.315 million (previous year: €3.15 million), the equity ratio from 48 to 90%.
Further growth planned
In 2007, Nanogate plans to conquer new markets and applications which will enable a significant increase in sales and growth. The company is addressing market segments with potential sales figures in at least double-digit millions. More concretely, working with its clients, Nanogate plans to introduce at least ten product innovations on the basis of Nanogate technologies. Growth is expected particularly in the segments automotive/mechanical engineering, buildings/interiors and sport/leisure. The company also plans to work together with further high-performance partners, secure long-term joint-ventures agreements and extend its international market position. Capital expenditure is to be increased to take the company forward into the next growth dimension. Investment is planned in the development of new and additional technology platforms, in sales and marketing and in production capacity.
Ralf Zastrau, Chairman of the Management Board of Nanogate AG said: "Nanogate is operating from a strong position, but we are not resting on our successes. Nanogate will take every opportunity presented to extend the potential of nanotechnology to clients from different industries. We are convinced that there will be considerable growth in the future."
About Nanogate AG
The Nanogate AG is an internationally leading enabler in the growth market of nanotechnology. We enhance our customers´ and partners´ products, hence providing them with extra added value and a competitive edge. We open the gateway to nanotechnology for the most varied of industrial sectors.
Taking Nanogate Technologie® as a basis, we create new functions by programming materials. From the development and production of innovative nano composites and nano formulations through to comprehensive product and process integration, we offer competence as a partner in innovation and implementation. Take advantage of our added value potential!
For more information, please click here
Public & Investor Relations GmbH
Tel. +49 (0)69/959290-0
Fax +49 (0)69/ 959290-29
Copyright © Nanogate AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016
Nanobiotix revenue for Q2 2016 July 14th, 2016